<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03207048</url>
  </required_header>
  <id_info>
    <org_study_id>Guangzhou Psychiatric Hospital</org_study_id>
    <nct_id>NCT03207048</nct_id>
  </id_info>
  <brief_title>A Study of Repetitive Transcranial Magnetic Stimulation in Bipolar Patients</brief_title>
  <official_title>Repetitive Transcranial Magnetic Stimulation (rTMS) to Improve Cognitive Function and Prevent Relapses in Bipolar Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangzhou Psychiatric Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangzhou Psychiatric Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the effect of Repetitive transcranial magnetic stimulation (rTMS)
      on cognition and long-term clinical outcomes of bipolar patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cognitive deficits are core features of bipolar disorder. Preliminary evidence shows that
      repetitive transcranial magnetic stimulation (rTMS) might have positive effects in enhancing
      cognition and improving clinical symptoms in patients with depression. This study will
      investigate the effect of rTMS on cognition and long-term outcomes (12 month) of bipolar
      patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 10, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the MATRICS Consensus Cognitive Battery</measure>
    <time_frame>12 weeks (six weeks after the conclusion of rTMS treatment)</time_frame>
    <description>Changes in neurocognitive and social function (measured by the The MATRICS Consensus Cognitive Battery) after 2 session of rTMS treatments (20 times)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in depression severity [ Time Frame: Baseline to six weeks (after the conclusion of rTMS treatment) ]</measure>
    <time_frame>6 weeks</time_frame>
    <description>Measured by the 24-item Hamilton Rating Scale for Depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mania severity [ Time Frame: Baseline to six weeks (after the conclusion of rTMS treatment) ]</measure>
    <time_frame>6 weeks</time_frame>
    <description>measured by Young Mania Rating Scale (YMRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>relapses of depressive and/or hypo/mania episode</measure>
    <time_frame>12 months</time_frame>
    <description>The number of patients who have depression and/or hyop/mania episodes over period of 12 months.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Cognitive Impairment</condition>
  <condition>Relapse</condition>
  <condition>Bipolar Disorder</condition>
  <arm_group>
    <arm_group_label>Active rTMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 Hz repetitive transcranial magnetic stimulation (rTMS) applied to the left dorsolateral prefrontal cortex (L-DLPFC) for 15 mins each time, 5 times per week for up to 6 weeks (interrupt for 1-2 weeks after 10 times).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham rTMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham repetitive transcranial magnetic stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Repetitive Transcranial Magnetic Stimulation</intervention_name>
    <description>Daily left DLPFC, at 110% motor threshold, with a frequency of 10 Hz. Stimulation will be applied in 3-second trains with a 15-second inter-train interval, for 50 trains per session</description>
    <arm_group_label>Active rTMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham repetitive transcranial magnetic stimulation</intervention_name>
    <description>Sham Transcranial Magnetic Stimulation</description>
    <arm_group_label>Sham rTMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bipolar Type I or II subjects diagnosed according to the Diagnostic and Statistical
             Manual of Mental Disorders (DSM-5)

          -  Age 18-60 years

          -  Rating on 24-items Hamilton Depression Rating Scale (HAMD)&lt;18

          -  Rating on the Young Mania Rating Scale (YMRS) &lt; 12

        Exclusion Criteria:

          -  History of any DSM-IV Axis I diagnosis other than BD Type I or II

          -  Implanted medication pump or cardiac pacemaker;

          -  Have had prior brain surgery

          -  Any metal in the head (except in mouth)

          -  Any disease of increased Intracranial pressure

          -  Suicide attempt

          -  Pharmacotherapy

          -  unstable medical conditions

          -  in the process of changing and redrawing withdrawing psychoactive medications within
             the past 4 weeks (except for sleeping medications such as benzodiazepines)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>kangguang Lin, MD; PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guangzhou Brain hospital (Guangzhou Psychiatric Hospital)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kangguang Lin, MD, PhD</last_name>
    <phone>86-02081268189</phone>
    <email>klin@connect.hku.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guangzhou Brain hospital(Guangzhou Huiai Hospital)</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510370</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kangguang Lin, D.D;Ph.D</last_name>
      <phone>13560360144</phone>
      <email>klin@connect.hku.hk</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Martin DM, McClintock SM, Forster JJ, Lo TY, Loo CK. Cognitive enhancing effects of rTMS administered to the prefrontal cortex in patients with depression: A systematic review and meta-analysis of individual task effects. Depress Anxiety. 2017 Nov;34(11):1029-1039. doi: 10.1002/da.22658. Epub 2017 May 24. Review.</citation>
    <PMID>28543994</PMID>
  </reference>
  <reference>
    <citation>Kedzior KK, Schuchinsky M, Gerkensmeier I, Loo C. Challenges in comparing the acute cognitive outcomes of high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) vs. electroconvulsive therapy (ECT) in major depression: A systematic review. J Psychiatr Res. 2017 Aug;91:14-17. doi: 10.1016/j.jpsychires.2017.03.002. Epub 2017 Mar 2. Review.</citation>
    <PMID>28288306</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2017</study_first_submitted>
  <study_first_submitted_qc>June 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2017</study_first_posted>
  <last_update_submitted>July 10, 2017</last_update_submitted>
  <last_update_submitted_qc>July 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangzhou Psychiatric Hospital</investigator_affiliation>
    <investigator_full_name>Kangguang Lin</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bipolar Disorder</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

